Research Article
The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension
Table 1
Clinical and biochemical characteristics of the patients (means ± SD).
| | | HHD combined with PH | Total | value | | Present (n = 72) | Absent (n = 29) |
| | Sex (M : F) | 28 : 44 | 10 : 19 | 38 : 63 | 0.679 | | Smoking status (P : A) | 16 : 56 | 6 : 23 | 22 : 79 | 0.866 | | Goiter (P : A) | | 52 : 20 | 19 : 10 | 71 : 30 | 0.505 | | I | | 8 : 64 | 4 : 25 | 12 : 89 | | | II | | 32 : 40 | 8 : 21 | 40 : 61 | | | III | | 12 : 60 | 7 : 22 | 19 : 82 | | | Hypertension (P : A) | 9 : 63 | 4 : 25 | 13 : 88 | 0.861 | | Atrial fibrillation (P : A) | 24 : 48 | 7 : 22 | 31 : 70 | 0.365 | | Systolic BP (mmHg) | 126.4 ± 16.0 | 126.9 ± 14.5 | 126.6 ± 15.5 | 0.880 | | Diastolic BP (mmHg) | 76.8 ± 11.3 | 79.2 ± 10.2 | 77.5 ± 11.0 | 0.327 | | BMI | 22.3 ± 2.9 | 22.9 ± 3.9 | 22.5 ± 3.2 | 0.326 | | Age (years) | 47.5 ± 13.4 | 45.7 ± 13.9 | 46.9 ± 13.5 | 0.564 | | FT3 (pmol/l) | 22.3 ± 11.2 | 20.5 ± 10.9 | 21.8 ± 11.1 | 0.447 | | FT4 (pmol/l) | 67.6 ± 35.6 | 64.5 ± 42.2 | 66.8 ± 37.4 | 0.695 | | TSH (mIU/l) | 0.0075 ± 0.0099 | 1.713 ± 9.019 | 0.497 ± 4.835 | 0.317 | | TRAb (IU/l) | 23.9 ± 15.1 | 16.9 ± 11.0 | 21.9 ± 14.4 | 0.012 | | Anti-TPO (IU/ml) | 852.3 ± 503.8 | 767.4 ± 538.1 | 827.9 ± 512.6 | 0.454 | | Anti-TG (IU/ml) | 329.5 ± 511.1 | 366.5 ± 528.9 | 333.7 ± 514.1 | 0.687 |
|
|
TSH, thyroid stimulating hormone; FT4, free tetraiodotronin; FT3, free triiodotronin; TPOAb, anti-thyroid peroxidase antibody; TGAb, anti-thyroglobulin antibodies; TRAb, thyrotropin receptor antibody; BMI, body mass index.
|
